Thomson Reuters StreetEvents via Yahoo
Q1 2024 LifeMD Inc Earnings Call
First we plan to launch our hormone replacement therapy offering led by testosterone therapy. This offering not only presents a tremendous cross-sell opportunity for the existing Rex patient ...
13 minutes ago